CN111434345A - Formula and preparation process of moxa essential oil for relieving asthenopia - Google Patents
Formula and preparation process of moxa essential oil for relieving asthenopia Download PDFInfo
- Publication number
- CN111434345A CN111434345A CN201910027701.7A CN201910027701A CN111434345A CN 111434345 A CN111434345 A CN 111434345A CN 201910027701 A CN201910027701 A CN 201910027701A CN 111434345 A CN111434345 A CN 111434345A
- Authority
- CN
- China
- Prior art keywords
- essential oil
- filtering
- chinese mugwort
- relieving
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese mugwort essential oil formula for relieving asthenopia and a preparation process thereof, wherein the components comprise Chinese mugwort essential oil, base oil, lavender stock solution, purified water, cassia seed, Chinese angelica, tall gastrodia tuber and mint; meanwhile, the provided preparation process can realize better quality of the moxa essential oil.
Description
Technical Field
The invention relates to the field of essential oil processing, in particular to a formula of moxa essential oil for relieving eyestrain and a preparation process thereof.
Background
The main components of the Chinese mugwort essential oil are ethyl acetate, 1.8-cineole, hydrated camphene, camphor, 2-terpineol, carvone, thujone and isocupressine. The latter two are unique to Chinese mugwort essential oil, and other Chinese mugwort essential oils do not contain. The main effects of the traditional Chinese medicine composition comprise dispelling cold, eliminating dampness, relieving pain, resisting bacteria, diminishing inflammation, activating collaterals, warming channels, purifying and repairing skin and resisting aging. At present, the components of the moxa essential oil are different, and the components with the names of eyes such as cassia seed, angelica, gastrodia elata and the like are not added.
The invention discloses a Chinese mugwort essential oil and a preparation method and application thereof, wherein the preparation method comprises the following steps: collecting folium Artemisiae Argyi which is naturally dried during 6-month middle ten days of Aglaia in Hubei, pulverizing, and loading into supercritical extraction device; heating in water bath to make the supercritical extraction device reach a set temperature, introducing CO2, and replacing air in the system; adjusting the pressure in the supercritical extraction device, adjusting an outlet valve to enable the flow of CO2 to reach a required stable value, and maintaining the system in the state for 50-70 min to obtain an essential oil crude product; adding the extracted crude product of the essential oil into absolute ethyl alcohol, stirring, standing, carrying out vacuum filtration, removing the precipitated waxy components, and recovering ethanol from the filtrate under reduced pressure to obtain the dewaxed Chinese mugwort essential oil. The application of the Chinese mugwort essential oil in preventing and relieving chronic inflammatory diseases is low in price, has obvious curative effect in preventing and relieving the chronic inflammatory diseases, and develops a convenient using method.
The formula of the Chinese mugwort essential oil is obviously different from that of the invention, and the essential oil in the invention is added with the components of cassia seed, angelica and rhizoma gastrodiae, so that the using effect is more abundant, and in addition, the preparation process of the essential oil in the invention is more convenient and faster.
Disclosure of Invention
The formula of the moxa essential oil for relieving eye fatigue comprises the following components:
1-2% of Chinese mugwort essential oil, 3-8% of base oil, 60-80% of lavender stock solution, 8-20% of purified water, 1-3% of cassia seed, 1-3% of Chinese angelica, 0-2% of rhizoma gastrodiae and 0-3% of mint.
A preparation process of moxa essential oil for relieving asthenopia comprises the following steps:
(1) preparing raw materials: selecting high-quality and pollution-free Chinese mugwort to ensure that the Chinese mugwort is free from wormhole and corruption;
(2) cleaning and soaking: cleaning the Chinese mugwort with a cleaning agent;
(3) grinding and crushing: grinding the prepared Chinese mugwort, cassia seed, angelica, gastrodia elata and mint in a grinding machine at the rotation speed of 2000-;
(4) fermentation and mixing: placing the mixture obtained in the step (3) in an environment of 25-40 ℃ for fermentation treatment, wherein the treatment time is 24-48 h;
(5) and (3) filtering: filtering the fermented mixture to obtain a Chinese mugwort mixed stock solution;
(6) and (3) distillation: distilling the obtained stock solution at the temperature of 350-420 ℃ to obtain a mixed essential oil crude product;
(7) component preparation: mixing the mixed essential oil crude product, the base oil and the lavender stock solution according to a formula ratio, and after mixing, carrying out centrifugation for layering, wherein the centrifugation speed is 5000-;
(8) blending and configuring: blending the mixed refined essential oil and purified water according to the formula ratio, and mixing and shaking up to obtain the finished product.
Preferably, the content of the gastrodia elata and the mint is not zero.
Preferably, the base oil is natural safflower seed oil.
Preferably, the purified water is ultra-filtered ultrapure water.
Preferably, the cleaning agent comprises gelatin hydrolysate, sodium citrate and Kathon 886.
Preferably, the preparation method of the cleaning agent comprises the following steps: 3.0kg of gelatin hydrolysate, 7.0kg of sodium citrate and Kathon8860.lkg are mixed with water according to the ratio of 1:100 and dissolved into liquid.
Preferably, the filtering in the step (5) comprises coarse filtering and fine filtering, wherein the coarse filtering adopts a 50-mesh screen to filter the fermentation mixture, and the fine filtering adopts 200 meshes to further filter the liquid after the coarse filtering.
Has the advantages that: the invention has provided a Chinese mugwort essential oil formulation and its preparation method to relieve asthenopia, its ingredient includes Chinese mugwort essential oil, base oil, lavender stock solution, purified water, semen Cassiae, Angelica sinensis, rhizoma Gastrodiae, peppermint, use Chinese mugwort essential oil of this formulation on the one hand, Chinese mugwort essential oil possesses effects such as dispelling cold, dispelling dampness, relieving pain, antibacterial, diminishing inflammation, activating collateral flow, warming channel, purifying and repairing skin, resisting aging, etc., have effects of warming and nourishing and activating collaterals, promoting the blood circulation of the eye, relieve asthenopia, semen Cassiae, Angelica sinensis, rhizoma Gastrodiae ingredient added at the same time have effects of famous eyes, it is very effective to the health-care function of the eye; the preparation technology who provides simultaneously can realize that the quality of chinese mugwort essential oil is better, the content of gastrodia elata and peppermint is not zero, and this composition has health care effect to the eye, and what the base oil adopted is natural safflower seed oil, and this kind of oil is nonirritant to the eye for healthy oil, the pure water is the ultrapure water through ultrafiltration treatment, and the impurity that ultrapure water contains is very few, can reduce essential oil package and breed the bacterium for chinese mugwort essential oil package keeps clean for a long time, the composition of cleaner includes gelatin hydrolysate, sodium citrate, Kathon886, the preparation method of cleaner is: mixing 3.0kg of gelatin hydrolysate, 7.0kg of sodium citrate, Kathon8860.lkg and water according to a ratio of 1:100 to dissolve into a solution, wherein the cleaning agent can effectively remove impurities on the surface of the Chinese mugwort and simultaneously can prevent the effective components of the Chinese mugwort from being damaged, the filtering in the step (5) comprises rough filtering and fine filtering, the rough filtering adopts a 50-mesh screen to filter the fermentation mixture, the fine filtering adopts 200 meshes to further filter the liquid after the rough filtering, and the process can quickly remove solid impurities in the fermentation mixture and is convenient for the subsequent processing of essential oil.
Detailed Description
In order to make the technical means, the creation characteristics, the achievement purposes and the effects of the invention easy to understand, the invention is further described with the specific embodiments.
Example 1:
a formula of moxa essential oil for relieving asthenopia comprises the following components: 1% of Chinese mugwort essential oil, 3% of natural safflower seed oil, 77% of lavender stock solution, 15% of ultrapure water, 1% of cassia seed, 1% of Chinese angelica, 1% of gastrodia elata and 1% of mint.
A preparation process of moxa essential oil for relieving asthenopia comprises the following steps:
(1) preparing raw materials: selecting high-quality and pollution-free Chinese mugwort to ensure that the Chinese mugwort is free from wormhole and corruption;
(2) cleaning and soaking: cleaning folium Artemisiae Argyi with cleaning agent, which comprises gelatin hydrolysate, sodium citrate, and Kathon886, and is prepared by the following steps: mixing and dissolving 3.0kg of gelatin hydrolysate, 7.0kg of sodium citrate, Kathon8860.lkg and water according to the ratio of 1:100 to obtain a solution;
(3) grinding and crushing: grinding folium Artemisiae Argyi, semen Cassiae, radix Angelicae sinensis, rhizoma Gastrodiae and herba Menthae in a mill at 2000 r/min;
(4) fermentation and mixing: placing the mixture obtained in the step (3) in an environment of 25 ℃ for fermentation treatment, wherein the treatment time is 24 hours;
(5) and (3) filtering: filtering the fermented mixture to obtain mixed stock solution of folium Artemisiae Argyi, and filtering including coarse filtering and fine filtering, wherein the coarse filtering adopts 50 mesh screen to filter the fermented mixture, and the fine filtering adopts 200 mesh to further filter the coarse filtered liquid;
(6) and (3) distillation: distilling the obtained stock solution at 350 deg.C to obtain crude product of mixed essential oil;
(7) component preparation: mixing the mixed crude essential oil, the base oil and the lavender stock solution according to a formula ratio, mixing, centrifuging for layering at a centrifugal speed of 5000r/min for 30-50min, and removing water and impurities to obtain a fine mixed essential oil product;
(8) blending and configuring: blending the mixed refined essential oil and purified water according to the formula ratio, and mixing and shaking up to obtain the finished product.
Example 2:
a formula of moxa essential oil for relieving asthenopia comprises the following components: 2% of Chinese mugwort essential oil, 5% of natural safflower seed oil, 70% of lavender stock solution, 15% of ultrapure water, 2% of cassia seed, 2% of Chinese angelica, 2% of gastrodia elata and 2% of mint.
A preparation process of moxa essential oil for relieving asthenopia comprises the following steps:
(1) preparing raw materials: selecting high-quality and pollution-free Chinese mugwort to ensure that the Chinese mugwort is free from wormhole and corruption;
(2) cleaning and soaking: cleaning folium Artemisiae Argyi with cleaning agent, which comprises gelatin hydrolysate, sodium citrate, and Kathon886, and is prepared by the following steps: mixing and dissolving 3.0kg of gelatin hydrolysate, 7.0kg of sodium citrate, Kathon8860.lkg and water according to the ratio of 1:100 to obtain a solution;
(3) grinding and crushing: grinding folium Artemisiae Argyi, semen Cassiae, radix Angelicae sinensis, rhizoma Gastrodiae and herba Menthae in a mill at 4000 r/min;
(4) fermentation and mixing: placing the mixture obtained in the step (3) in an environment of 32 ℃ for fermentation treatment, wherein the treatment time is 36 h;
(5) and (3) filtering: filtering the fermented mixture to obtain mixed stock solution of folium Artemisiae Argyi, and filtering including coarse filtering and fine filtering, wherein the coarse filtering adopts 50 mesh screen to filter the fermented mixture, and the fine filtering adopts 200 mesh to further filter the coarse filtered liquid;
(6) and (3) distillation: distilling the obtained stock solution at 380 deg.C to obtain crude product of mixed essential oil;
(7) component preparation: mixing the mixed crude essential oil, the base oil and the lavender stock solution according to a formula ratio, mixing, centrifuging for layering, centrifuging at a rotating speed of 7500r/min for 40min, and removing water and impurities to obtain a fine mixed essential oil product;
(8) blending and configuring: blending the mixed refined essential oil and purified water according to the formula ratio, and mixing and shaking up to obtain the finished product.
Example 3:
a formula of moxa essential oil for relieving asthenopia comprises the following components: 2% of Chinese mugwort essential oil, 8% of natural safflower seed oil, 60% of lavender stock solution, 19% of ultrapure water, 3% of cassia seed, 3% of Chinese angelica, 2% of gastrodia elata and 3% of mint.
A preparation process of moxa essential oil for relieving asthenopia comprises the following steps:
(1) preparing raw materials: selecting high-quality and pollution-free Chinese mugwort to ensure that the Chinese mugwort is free from wormhole and corruption;
(2) cleaning and soaking: cleaning folium Artemisiae Argyi with cleaning agent, which comprises gelatin hydrolysate, sodium citrate, and Kathon886, and is prepared by the following steps: mixing and dissolving 3.0kg of gelatin hydrolysate, 7.0kg of sodium citrate, Kathon8860.lkg and water according to the ratio of 1:100 to obtain a solution;
(3) grinding and crushing: grinding folium Artemisiae Argyi, semen Cassiae, radix Angelicae sinensis, rhizoma Gastrodiae and herba Menthae in a mill at 5000 r/min;
(4) fermentation and mixing: placing the mixture obtained in the step (3) in an environment of 40 ℃ for fermentation treatment, wherein the treatment time is 48 h;
(5) and (3) filtering: filtering the fermented mixture to obtain mixed stock solution of folium Artemisiae Argyi, and filtering including coarse filtering and fine filtering, wherein the coarse filtering adopts 50 mesh screen to filter the fermented mixture, and the fine filtering adopts 200 mesh to further filter the coarse filtered liquid;
(6) and (3) distillation: distilling the obtained stock solution at 420 ℃ to obtain a crude mixed essential oil product;
(7) component preparation: mixing the mixed crude essential oil, the base oil and the lavender stock solution according to a formula ratio, and after mixing, carrying out centrifugation for layering at a centrifugation speed of 8000r/min for 50min to remove water and impurities to obtain a mixed refined essential oil;
(8) blending and configuring: blending the mixed refined essential oil and purified water according to the formula ratio, and mixing and shaking up to obtain the finished product.
Samples of each example were taken for assay analysis and compared to the prior art to yield the following data:
according to the data in the table, when the parameters of the example 2 are implemented, the formula of the wormwood essential oil for relieving the asthenopia and the preparation process thereof have the advantages that the wormwood essential oil has the nominal effect, the contents of heavy metals of lead, cadmium, mercury and bromine are 1.7mg/Kg, the content of biphenyl is 4.7mg/Kg, and no artificial ingredients, and the existing technical standard does not have the nominal effect, the contents of heavy metals of lead, cadmium, mercury and bromine are 5.0mg/Kg, the content of biphenyl is 12.0mg/Kg, and artificial ingredients are contained, so that the wormwood essential oil formula for relieving the asthenopia and the preparation process thereof have better eye health care effect, low heavy metal content, low content of organic harmful ingredients, and no artificial ingredients, and therefore, the wormwood essential oil formula has remarkable superiority.
The invention provides a Chinese mugwort essential oil formula for relieving asthenopia and a preparation process thereof, wherein the components comprise Chinese mugwort essential oil, base oil, lavender stock solution, purified water, cassia seed, Chinese angelica, tall gastrodia tuber and mint; the preparation technology who provides simultaneously can realize that the quality of chinese mugwort essential oil is better, the content of gastrodia elata and peppermint is not zero, and this composition has health care effect to the eye, the base oil adopts is natural safflower seed oil, and this kind of oil is the nonirritant to the eye for healthy oil, the pure water is the ultrapure water through ultrafiltration treatment, and the impurity that ultrapure water contains is very few, can reduce the essential oil package and nourish living bacterium for chinese mugwort essential oil package keeps clean for a long time, the composition of cleaner includes gelatin hydrolysate, sodium citrate, Kathon886, the preparation method of cleaner is: mixing and dissolving 3.0kg of gelatin hydrolysate, 7.0kg of sodium citrate and Kathon8860.lkg with water according to a ratio of 1:100 to obtain a solution, wherein the cleaning agent can effectively remove impurities on the surface of the Chinese mugwort and simultaneously can prevent the effective components of the Chinese mugwort from being damaged, the filtering in the step (5) comprises rough filtering and fine filtering, the rough filtering adopts a 50-mesh screen to filter the fermentation mixture, the fine filtering adopts 200 meshes to further filter the liquid after the rough filtering, and the process can quickly remove solid impurities in the fermentation mixture and facilitate the subsequent processing of essential oil.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various changes and modifications can be made without departing from the inventive concept of the present invention, and these changes and modifications are all within the scope of the present invention.
Claims (8)
1. The formula of the moxa essential oil for relieving eye fatigue is characterized by comprising the following components in parts by weight:
1-2% of Chinese mugwort essential oil, 3-8% of base oil, 60-80% of lavender stock solution, 8-20% of purified water, 1-3% of cassia seed, 1-3% of Chinese angelica, 0-2% of rhizoma gastrodiae and 0-3% of mint.
2. The formulation of essential oil of wormwood for relieving asthenopia according to claim 1, wherein the content of gastrodia elata and mint is not zero.
3. The formulation of moxa essential oil for alleviating eye fatigue of claim 1, wherein the base oil is natural safflower seed oil.
4. The moxa essential oil formulation for relieving asthenopia according to claim 1, wherein the purified water is ultra-filtered ultrapure water.
5. The preparation process of the moxa essential oil formula for relieving asthenopia of any one of 1-4 is characterized by comprising the following steps of:
(1) preparing raw materials: selecting high-quality and pollution-free Chinese mugwort to ensure that the Chinese mugwort is free from wormhole and corruption;
(2) cleaning and soaking: cleaning the Chinese mugwort with a cleaning agent;
(3) grinding and crushing: grinding the prepared Chinese mugwort, cassia seed, angelica, gastrodia elata and mint in a grinder at the rotation speed of 2000-;
(4) fermentation and mixing: placing the mixture obtained in the step (3) in an environment of 25-40 ℃ for fermentation treatment, wherein the treatment time is 24-48 h;
(5) and (3) filtering: filtering the fermented mixture to obtain a Chinese mugwort mixed stock solution;
(6) and (3) distillation: distilling the obtained stock solution at the temperature of 350-420 ℃ to obtain a mixed essential oil crude product;
(7) component preparation: mixing the mixed essential oil crude product, the base oil and the lavender stock solution according to a formula ratio, and layering by centrifugation at a centrifugation speed of 5000-;
(8) blending and configuring: blending the mixed refined essential oil and purified water according to the formula ratio, and mixing and shaking up to obtain the finished product.
6. The preparation process of the asthenopia-relieving artemisia argyi essential oil as claimed in claim 5, wherein the components of the cleaning agent comprise gelatin hydrolysate, sodium citrate and Kathon 886.
7. The preparation process of the artemisia argyi essential oil for relieving the asthenopia as claimed in claim 6, wherein the preparation method of the cleaning agent is as follows: 3.0kg of gelatin hydrolysate, 7.0kg of sodium citrate and Kathon8860.lkg are mixed with water according to the ratio of 1:100 and dissolved into liquid.
8. The process for preparing artemisia argyi essential oil for relieving asthenopia as claimed in claim 5, wherein the filtering in step (5) comprises coarse filtering and fine filtering, wherein the coarse filtering is performed by using a 50-mesh screen to filter the fermented mixture, and the fine filtering is performed by using a 200-mesh screen to further filter the liquid after coarse filtering.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910027701.7A CN111434345A (en) | 2019-01-11 | 2019-01-11 | Formula and preparation process of moxa essential oil for relieving asthenopia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910027701.7A CN111434345A (en) | 2019-01-11 | 2019-01-11 | Formula and preparation process of moxa essential oil for relieving asthenopia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111434345A true CN111434345A (en) | 2020-07-21 |
Family
ID=71580334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910027701.7A Pending CN111434345A (en) | 2019-01-11 | 2019-01-11 | Formula and preparation process of moxa essential oil for relieving asthenopia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111434345A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101954028A (en) * | 2009-07-21 | 2011-01-26 | 唐显 | Medicinal pillow for preventing and treating myopic eyes |
| CN104586934A (en) * | 2013-11-04 | 2015-05-06 | 岑春华 | A manufacturing and treating method of a magnetic wine stone rehabilitation belt applying acupuncture points with medicines |
| CN104688813A (en) * | 2015-03-12 | 2015-06-10 | 施敬东 | Nerve-soothing and eye-relaxing pad and preparation method thereof |
| CN106943227A (en) * | 2017-04-17 | 2017-07-14 | 遂昌维康竹炭开发有限公司 | Eyeshade is maintained in a kind of hot compress |
| CN107233403A (en) * | 2017-06-09 | 2017-10-10 | 李时珍医药集团有限公司 | A kind of water profit champignon eyeshield spraying and preparation method thereof |
| CN206660294U (en) * | 2016-08-11 | 2017-11-24 | 湖北艾立方科技有限公司 | A kind of health care eye sticker with cosmetology function |
-
2019
- 2019-01-11 CN CN201910027701.7A patent/CN111434345A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101954028A (en) * | 2009-07-21 | 2011-01-26 | 唐显 | Medicinal pillow for preventing and treating myopic eyes |
| CN104586934A (en) * | 2013-11-04 | 2015-05-06 | 岑春华 | A manufacturing and treating method of a magnetic wine stone rehabilitation belt applying acupuncture points with medicines |
| CN104688813A (en) * | 2015-03-12 | 2015-06-10 | 施敬东 | Nerve-soothing and eye-relaxing pad and preparation method thereof |
| CN206660294U (en) * | 2016-08-11 | 2017-11-24 | 湖北艾立方科技有限公司 | A kind of health care eye sticker with cosmetology function |
| CN106943227A (en) * | 2017-04-17 | 2017-07-14 | 遂昌维康竹炭开发有限公司 | Eyeshade is maintained in a kind of hot compress |
| CN107233403A (en) * | 2017-06-09 | 2017-10-10 | 李时珍医药集团有限公司 | A kind of water profit champignon eyeshield spraying and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 张智银: "穴位贴压治疗儿童弱视44例", 《河南中医》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102526315B (en) | Preparation method of extracts of effective fractions of lychee seeds | |
| CN108888676A (en) | A kind of Chinese medicine composition and preparation method thereof for treating eczema | |
| CN102860445A (en) | Preparation method for honeycomb element cream | |
| CN111346161A (en) | Essential oil composition for treating rhinitis and preparation method thereof | |
| CN106491856A (en) | Hyaluronic acid bacteriostatic gel | |
| CN103704414B (en) | Herbal tea and preparation method thereof | |
| WO2020220863A1 (en) | Method for preparing cannabis sativa l. oil and cannabis sativa l. oil prepared thereby | |
| CN111434345A (en) | Formula and preparation process of moxa essential oil for relieving asthenopia | |
| CN104971088A (en) | Tibetan artemisia capillaris extract and preparation method, drug composition and application thereof | |
| CN114983902B (en) | Skin care composition containing pseudo-ginseng and preparation method thereof | |
| CN110090180B (en) | Cosmetic lithospermum extract and preparation method thereof | |
| CN111434343A (en) | Formula and preparation process of moxa essential oil for steam eye mask | |
| CN116850228B (en) | Pseudo-ginseng ointment for treating traumatic injuries and rheumatism and preparation method thereof | |
| CN105746807A (en) | Fructus momordicae tea drink for removing smaze, wetting throat and clearing away lung-heat and making method of fructus momordicae tea drink | |
| CN105395893A (en) | Oral solution for clearing heat from throat and preparation method thereof | |
| CN111647492A (en) | Radix puerariae and bamboo leaf green wine and preparation method thereof | |
| CN101380341B (en) | Preparation method of compound propolis preparation | |
| CN112569287A (en) | Anti-allergy itching-relieving plant composition and preparation method and application thereof | |
| CN1817356A (en) | Production of vermilion injection for treating cardiovascular disease | |
| TW201932133A (en) | Extracting method of cordyceps cicadae extract and the purpose thereof | |
| CN107260595A (en) | One Plant Extracts antiallergy cream and preparation method thereof | |
| CN106880656A (en) | Blood-activating and pain-stopping capsules | |
| CN107496491A (en) | A kind of preparation method of blood-activating pain stopping tablet | |
| CN105497438A (en) | Nano antibacterial gel for trauma nursing and preparation method thereof | |
| CN117398329A (en) | Composite tea bag for improving dysmenorrhea, preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200721 |